Farid Khan

About Farid Khan

With 26 years in pharmaceutical research and development and currently as Director of Evidence Generation at Novartis, I have led the execution of real-world evidence (RWE) and observational studies for US and Global Medical Affairs teams to support the clinical development of disease-modifying therapies for neuroscience and rare disease indications - Myathenia Gravis, ALS, Rett Syndrome, Friedreich\'s Ataxia and Spinal Muscular Atrophy.I am excited about the FDA releasing the following statement recently:\"We\'re removing unnecessary barriers that have prevented us from using powerful real-world evidence to get life-changing treatments to patients faster.\" It is an endorsement of the crucial role of real-world evidence in the drug development process.I am particulary passionate about advancing innovative and transformational treatments that enhance the lives of patients and their families that are struggling with rare disease. Having been part of the launch of a gene replacement therapy for SMA, a rare genetic neuromuscular disorder, has allowed me to witness first-hand the tremendous impact it has had.In my early years of medical training as a young surgeon it was impressive to see immediate results on the health of patients I operated on. As a researcher, I am excited by the promise of gene therapies and their potential to be just as impactful or even more so for complicated medical conditions with enormous burden of disease.

Experience

1. Director Evidence Generation - Global Medical Affairs

   Novartis

   Feb 2024 — Present

   Lead evidence generation and RWE initiatives in Global Medical Affairs forneuroscience indications - Generalized Myasthenia Gravis and Cystinosis• Provide cross functional leadership in the development and execution of an enterprisestrategy on the acquisition and use of real-world data by Novartis• Optimally lead and leverage external and internal registries to gather real-worlddata for assets throughout from early development to commercialization• Perform critical analyses of medical and scientific evidence from registries - RWE andeconomic evaluations as the basis for regulatory and HTA assessments, and diseasemanagement guidelines• Collaborate with HEOR, Value and Access, Clinical Development and PatientAdvocacy to identify data gaps and develop evidence generation strategy to addressthem• Contribute to the Integrated Evidence Plan and the Clinical DevelopmentPlan or Global medical Affairs• Work with Scientific Communications to publish abstracts and manuscriptsin peer-reviewed scientific journals and present these at congresses andconferences

Education

• Albert Schweitzer Hospital of Hatvan

  Medical Residency, General Surgery

• University of Debrecen

  Doctor of Medicine - MD, Medicine

Skills

• Ich-Gcp
• Clinical Development
• Neuroscience
• Clinical Research
• Medical Affairs
• Medicine
• Business Strategy
• Edc
• Ctms
• Strategic Planning
• Drug Development
• Cancer
• Gcp
• Hospitals
• Healthcare Management
• Medical Writing
• CRO
• Leadership
• Clinical Trials
• Immunology
• Business Development
• Marketing Strategy
• Marketing
• Infectious Diseases
• Clinical Monitoring
• Life Sciences
• Oncology
• Team Leadership
• Lifesciences
• Management
• Research
• Pharmaceutical Industry
• Business Planning